platinum-resistant ovarian cancer

ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
Clinical Trials Arena
Wed, 05/17/23 - 10:50 pm
Immunogen
Elahere
clinical trials
platinum-resistant ovarian cancer
ovarian cancer
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
Clinical Trials Arena
Thu, 05/4/23 - 09:17 am
Immunogen
clinical trial
ovarian cancer
platinum-resistant ovarian cancer
Elahere
OncoC4 doses first participant in ovarian cancer therapy trial
Clinical Trials Arena
Mon, 01/2/23 - 06:33 pm
OncoC4
clinical trials
ONC-392
Merck
Keytruda
ovarian cancer
platinum-resistant ovarian cancer
Compugen COM701 in dual/triple combo shows promise in ovarian cancer patients in trial
Seeking Alpha
Tue, 12/6/22 - 10:31 am
CompuGen
COM701
Bristol Myers Squibb
Opdivo
ovarian cancer
platinum-resistant ovarian cancer
Novocure launches pivotal ovarian cancer trial
Drug Delivery Business News
Fri, 03/22/19 - 10:19 am
Novocure
devices
ovarian cancer
platinum-resistant ovarian cancer
clinical trials
tumor treating fields
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
CP Wire
Mon, 08/20/18 - 09:58 am
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
Aravive Biologics’ Treatment For Platinum-Resistant Recurrent Ovarian Cancer Receives Fast Track Designation
Mon, 08/20/18 - 09:44 am
Aravive Biologics
AVB-S6-500
ovarian cancer
platinum-resistant ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
CP Wire
Fri, 04/27/18 - 01:18 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
Fri, 04/27/18 - 01:19 pm
Immunogen
mirvetuximab soravtansine
ovarian cancer
platinum-resistant ovarian cancer
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer (TSRO)
CP Wire
Mon, 03/26/18 - 02:48 pm
Tesaro
Zejula
Merck
Keytruda
platinum-resistant ovarian cancer
niraparib
clinical trials vaccines
Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer
Mon, 03/26/18 - 02:41 pm
Tesaro
Zejula
Merck
Keytruda
platinum-resistant ovarian cancer
niraparib
clinical trials
Oxigene Receives Fast Track Designation From U.S. FDA for CA4P
Yahoo
Wed, 03/30/16 - 10:15 am
Oxigene
fast track
FDA
CA4P
ovarian cancer
platinum-resistant ovarian cancer